Conformal intensity modulated radiation therapy for localized prostate cancer: Toward a new standard;Radiothérapie de conformation avec modulation d'intensité dans le cancer de prostate : vers un nouveau standard

Cancer/Radiotherapie

Volumn 13, Issue 5, 2009, Pages 409-415

  Azria, D ^a   Ailleres N ^a   Llacer Moscardo, C ^a   Hay, M H ^a   Dubois, J B ^a   Fenoglietto, P ^a  

^a INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

Author keywords

Intensity modulation; Prostate cancer; Radiotherapy

Indexed keywords

CANCER CONTROL; CANCER LOCALIZATION; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; HORMONAL THERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; ORGAN; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; RADIATION FIELD; SHORT SURVEY; THERAPY EFFECT; TREATMENT PLANNING; VOLUMETRY;

HUMANS; MALE; MOVEMENT; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; SEMINAL VESICLES; URINARY BLADDER;

EID: 68749115151     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2008.12.004     Document Type: Short Survey

References (37)

1. Ailleres N., Azria D., Thezenas S., Barbier N., Fenoglietto P., Delard R., et al. Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer. Cancer Radiother 8 (2004) 59-69
2. Arcangeli S., Saracino B., Petrongari M.G., Gomellini S., Marzi S., Landoni V., et al. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area. Radiother Oncol 84 (2007) 148-155
3. Artignan X., Rastkhah M., Balosso J., Fourneret P., Gilliot O., and Bolla M. Quantification des mouvements prostatiques lors de l'irradiation prostatique. Cancer Radiother 10 (2006) 381-387
4. Beckendorf V., Guerif S., Le Prise E., Cosset J.M., Lefloch O., Chauvet B., et al. The GETUG 70 Gy vs 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity. Int J Radiat Oncol Biol Phys 60 (2004) 1056-1065
5. Bey P., Beckendorf V., Aletti P., and Marchesi V. La radiothérapie conformationnelle dans le cancer de la prostate : pour qui et comment ?. Cancer Radiother 6 (2002) 147-153
6. Bey P., Beckendorf V., and Stines J. Prostate cancer. Cancer Radiother 5 (2001) 560-570
7. Chapet O., Quero L., Azria D., Bossi A., Hennequin C., and Paparele P. L'irradiation pelvienne est-elle toujours justifiée dans le traitement des cancers de la prostate par irradiation exclusive ?. Cancer Radiother 13 (2009) 416-422
8. Chavaudra J., and Bridier A. Definition of volumes in external radiotherapy: ICRU reports 50 and 62. Cancer Radiother 5 (2001) 472-478
9. de Crevoisier R., Lagrange J.L., Messai T., M'Barek B., and Lefkopoulos D. Dispositifs de repositionnement prostatique sous l'accélérateur linéaire. Cancer Radiother 10 (2006) 394-401
10. Dearnaley D.P., Khoo V.S., Norman A.R., Meyer L., Nahum A., Tait D., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 353 (1999) 267-272
11. Dubois J.B. Principes généraux de la radiothérapie de conformation. Cancer Radiother 2 (1998) 78
12. Fenoglietto P., Laliberte B., Allaw A., Ailleres N., Idri K., Hay M.H., et al. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk. Radiother Oncol 88 (2008) 77-87
13. Hanks G.E., Martz K.L., and Diamond J.J. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys 15 (1988) 1299-1305
14. Hill C., and Doyon F. La fréquence des cancers en France en 2005 : évolution de la mortalité depuis 1950 et résumés du rapport sur les causes de cancers. Bull Cancer 95 (2008) 5-10
15. Koper P.C., Stroom J.C., van Putten W.L., Korevaar G.A., Heijmen B.J., Wijnmaalen A., et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study. Int J Radiat Oncol Biol Phys 43 (1999) 727-734
16. Langen K.M., and Jones D.T. Organ motion and its management. Int J Radiat Oncol Biol Phys 50 (2001) 265-278
17. Malone S., Crook J.M., Kendal W.S., and Szanto J. Respiratory-induced prostate motion: quantification and characterization. Int J Radiat Oncol Biol Phys 48 (2000) 105-109
18. Michalski J.M., Purdy J.A., Winter K., Roach III M., Vijayakumar S., Sandler H.M., et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 46 (2000) 391-402
19. Muren L.P., Wasbo E., Helle S.I., Hysing L.B., Karlsdottir A., Odland O.H., et al. Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: planning procedures and early experiences. Int J Radiat Oncol Biol Phys 71 (2008) 1034-1041
20. Peeters S.T., Heemsbergen W.D., van Putten W.L., Slot A., Tabak H., Mens J.W., et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 61 (2005) 1019-1034
21. Peschel R.E., and Colberg J.W. Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol 4 (2003) 233-241
22. Pollack A., and Zagars G.K. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys 39 (1997) 1011-1018
23. Pollack A., Zagars G.K., Smith L.G., Lee J.J., von Eschenbach A.C., Antolak J.A., et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 18 (2000) 3904-3911
24. Pollack A., Zagars G.K., Starkschall G., Antolak J.A., Lee J.J., Huang E., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
25. Purdy J.A. Intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 35 (1996) 845-846
26. Roach III M., Pickett B., Weil M., and Verhey L. The "critical volume tolerance method" for estimating the limits of dose escalation during three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 35 (1996) 1019-1025
27. Sanchez-Doblado F., Hartmann G.H., Pena J., Capote R., Paiusco M., Rhein B., et al. Uncertainty estimation in intensity-modulated radiotherapy absolute dosimetry verification. Int J Radiat Oncol Biol Phys 68 (2007) 301-310
28. Société française de radiothérapie oncologique. Guides procédures de radiothérapie externe 2007. Cancer Radiother 2008;12:141-314.
29. Teh B.S., Woo S.Y., and Butler E.B. Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology. Oncologist 4 (1999) 433-442
30. Woo S.Y., Sanders M., Grant W., and Butler E.B. Does the "peacock" have anything to do with radiotherapy?. Int J Radiat Oncol Biol Phys 29 (1994) 213-214
31. Zelefsky M.J., Cowen D., Fuks Z., Shike M., Burman C., Jackson A., et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 85 (1999) 2460-2468
32. Zelefsky M.J., Fuks Z., Happersett L., Lee H.J., Ling C.C., Burman C.M., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 55 (2000) 241-249
33. Zelefsky M.J., Fuks Z., Hunt M., Lee H.J., Lombardi D., Ling C.C., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166 (2001) 876-881
34. Zelefsky M.J., Fuks Z., Hunt M., Yamada Y., Marion C., Ling C.C., et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53 (2002) 1111-1116
35. Zelefsky M.J., Happersett L., Leibel S.A., Burman C.M., Schwartz L., Dicker A.P., et al. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 37 (1997) 13-19
36. Zelefsky M.J., Leibel S.A., Gaudin P.B., Kutcher G.J., Fleshner N.E., Venkatramen E.S., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41 (1998) 491-500
37. Zelefsky M.J., Levin E.J., Hunt M., Yamada Y., Shippy A.M., Jackson A., et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 1124-1129